Description: PsyBio is a biotechnology company developing novel formulations of psychoactive medications using genetically modified bacteria for the treatment of mental health and other disorders. The team has experience in drug discovery based on synthetic biology and clinical and regulatory experience moving drugs through human studies and regulatory protocols. Research and development are currently ongoing for natural occurring tryptamines in different varieties of magic mushrooms, dimethyltryptamine and its derivatives, and mescaline and combinations thereof. The Company is also researching and developing new molecular structures that do not occur in nature which may have unique therapeutics properties.
Home Page: www.psybiolife.com
PSYB Technical Analysis
1624 Washington Street
Denver,
CO
80203
United States
Phone:
513 449 9585
Officers
| Name | Title |
|---|---|
| Mr. Evan Mike Levine | Co-Founder, CEO & Chairman |
| Mr. Noah Isidore Davis | CFO, Secretary & Director |
| Dr. Michael Spigarelli M.B.A., M.B.E., M.D., Ph.D. | Chief Scientific Officer & Chief Medical Officer |
| Mr. Ross Carmel | Chief Legal Officer & Director |
| Mr. Andrew Jones | Inventor & Chairman of Scientific Advisory Board |
Exchange: V
Country: CA : Canada
Currency: Canadian Dollar (C$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 183.2192 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |